Anxious depression and response to treatment

American Journal of Psychiatry

Volumn 165, Issue 3, 2008, Pages 297-299

  Nelson, J Craig ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; FLUOXETINE; IPRONIAZID; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY DISORDER; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EDITORIAL; HUMAN; PRIORITY JOURNAL; REMISSION; SOMATIZATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; META ANALYSIS; MULTICENTER STUDY; NOTE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

ANXIETY DISORDERS; CITALOPRAM; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; META-ANALYSIS AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 42449114896     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07121927     Document Type: Editorial

References (9)

1. West ED, Dally PJ: Effects of iproniazid in depressive syndromes. Br Med J 1959; 1:1491-1494
2. Paykel ES, Rowan PR, Parker RR, Bhat AV: Response to phenelzine and amitriptyline in subtypes of outpatient depression. Arch Gen Psychiatry 1982; 39:1041-1049
3. Ravaris CL, Robinson DS, Ives JO, Nies A, Bartlett D: Phenelzine and amitriptyline in the treatment of depression. Arch Gen Psychiatry 1980; 37:1075-1080
4. Tollefson GD, Holman SL, Sayler ME, Potvin JH: Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry 1994; 55:50-59
5. Fava M, Uebellacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF: Major depressive subtypes and treatment response. Biol Psychiatry 1997; 42:568-576
6. Davidson JRT, Meoni P, Haudiquet V, Cantillon M, Hackett D: Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depress Anxiety 2002; 16:4-13
7. Nelson JC, Delucchi K, Schneider LS: Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry (in press)
8. Papakostas GI, Stahl SM, Krishen A, Fava M: Efficacy of bupropion and the selective reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression). Presented at the annual meeting of the American College of Neuropharmacology, Boca Raton, Fla, Dec 11, 2007
9. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M, STAR*D Study Team: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163:28-40